EpiVario

Philadelphia, United States

EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.

Oct 2024

Grant

Top Investors

National Institute on Drug Abuse (NIDA)National Institute on Alcohol Abuse and Alcoholism

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are EpiVario's investors?

EpiVario's investors include National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism.

Where is EpiVario headquartered?

EpiVario is headquartered in Philadelphia, United States.

What does EpiVario do?

EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.

What stage is EpiVario at?

EpiVario is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 1, 2024.

MLA

"EpiVario — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/epivario. Accessed July 1, 2026.

APA

VCBacked. (2024). EpiVario — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/epivario

Wikipedia (cite web)

{{cite web |title=EpiVario — Funding & Investors |url=https://www.vcbacked.co/company/epivario |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 1, 2024.